KDKerr Ding

Kerr Ding

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kerr Ding has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multimodal protein representations across human brain cell types

    by Amy Dong, Michelle M. Li, Kerr Ding, Sumaiya Nazeen, Ayush Noori, Yepeng Huang, Shanghua Gao, Dylan Ritter, Jalwa Afroz, Alexander B. H. Henderson, et al.

    The central nervous system (CNS) comprises diverse cell types whose molecular context shapes the roles of the proteins they express. Computational models offer a scalable way to study the roles of proteins across human brain cell types, with protein language models and interactome- or single-cell-based models capturing complementary information encoded in protein sequences and cellular network contexts. Human brain tissue is hard to access, so brain cell types make up a small fraction of the atlases single-cell models train on and of the benchmarks used for their evaluation. To capture these complementary sources of information in the CNS, we introduce SEMPER, a multimodal representation learning model that aligns protein language model representations with protein-protein interaction networks from 442 cell types of the adult human brain, giving each protein a sequence-informed representation in every cell type in which its gene is expressed. We show that SEMPER representations predict cell type-specific protein complexes and predict genes essential to the survival of dopaminergic neurons, measured in a genome-wide CRISPR screen. In zero-shot retrieval, SEMPER recovers clinically pursued drug targets for Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, Huntington’s disease and amyotrophic lateral sclerosis at higher rates than cell type-specific models. To further improve target recovery, we combine SEMPER with a large language model that reasons over protein functional annotations. The combination recovers more targets, with SEMPER providing experimentally derived cellular context that complements literature-based reasoning of the large language model.

  • Top Cited Papers
    Open Access

    Machine learning-guided co-optimization of fitness and diversity facilitates combinatorial library design in enzyme engineering

    by Kerr Ding, Michael Chin, Yunlong Zhao, Wei Huang, Binh Khanh Mai, Huanan Wang, Peng Liu, Yang Yang, Yunan Luo

    The effective design of combinatorial libraries to balance fitness and diversity facilitates the engineering of useful enzyme functions, particularly those that are poorly characterized or unknown in biology. We introduce MODIFY, a machine learning (ML) algorithm that learns from natural protein sequences to infer evolutionarily plausible mutations and predict enzyme fitness. MODIFY co-optimizes predicted fitness and sequence diversity of starting libraries, prioritizing high-fitness variants while ensuring broad sequence coverage. In silico evaluation shows that MODIFY outperforms state-of-the-art unsupervised methods in zero-shot fitness prediction and enables ML-guided directed evolution with enhanced efficiency. Using MODIFY, we engineer generalist biocatalysts derived from a thermostable cytochromecto achieve enantioselective C-B and C-Si bond formation via a new-to-nature carbene transfer mechanism, leading to biocatalysts six mutations away from previously developed enzymes while exhibiting superior or comparable activities. These results demonstrate MODIFY’s potential in solving challenging enzyme engineering problems beyond the reach of classic directed evolution.


  • Open Access

    Leveraging conformal prediction to annotate enzyme function space with limited false positives

    by Kerr Ding, Jiaqi Luo, Yunan Luo

    Machine learning (ML) is increasingly being used to guide biological discovery in biomedicine such as prioritizing promising small molecules in drug discovery. In those applications, ML models are used to predict the properties of biological systems, and researchers use these predictions to prioritize candidates as new biological hypotheses for downstream experimental validations. However, when applied to unseen situations, these models can be overconfident and produce a large number of false positives. One solution to address this issue is to quantify the model’s prediction uncertainty and provide a set of hypotheses with a controlled false discovery rate (FDR) pre-specified by researchers. We propose CPEC, an ML framework for FDR-controlled biological discovery. We demonstrate its effectiveness using enzyme function annotation as a case study, simulating the discovery process of identifying the functions of less-characterized enzymes. CPEC integrates a deep learning model with a statistical tool known as conformal prediction, providing accurate and FDR-controlled function predictions for a given protein enzyme. Conformal prediction provides rigorous statistical guarantees to the predictive model and ensures that the expected FDR will not exceed a user-specified level with high probability. Evaluation experiments show that CPEC achieves reliable FDR control, better or comparable prediction performance at a lower FDR than existing methods, and accurate predictions for enzymes under-represented in the training data. We expect CPEC to be a useful tool for biological discovery applications where a high yield rate in validation experiments is desired but the experimental budget is limited.